Team

  • Priscilla Chan, M.D.

    Priscilla Chan, M.D.

    Co-Founder

    Priscilla Chan is the co-founder and co-CEO of the Chan Zuckerberg Initiative, where she leads efforts to advance biomedical research and technology to help scientists cure, prevent, or manage all disease. As a pediatrician, her firsthand experience caring for patients has fueled her commitment to accelerating scientific discovery. Priscilla’s leadership focuses on harnessing AI, building cutting-edge research tools, and funding innovative science to unlock new insights into human biology. She earned her bachelor's degree in biology from Harvard University and her doctor of medicine from the University of California, San Francisco, where she also completed her pediatrics residency.

  • Mark Zuckerberg

    Mark Zuckerberg

    Co-Founder

    Mark Zuckerberg is co-founder and co-CEO of the Chan Zuckerberg Initiative, where he brings deep technical expertise and experience building communities to inform the organization’s work. Mark is also the founder and CEO of Meta, where he leads the development of the company’s products and technology. He studied computer science at Harvard University before moving to Palo Alto, California, in 2004.

Investigator Program

Our investigator program supports research and collaborations by some of the best minds in science, medicine, engineering and technology.

Join us in our mission

We are a collaborative community of scientists, engineers, and AI and machine learning experts from across multiple fields who are passionate about tackling complex challenges and share a unified vision of a world without disease.

Large group photo of the Biohub team, arranged in three rows in front of a wall with the Biohub logo


Biohub carries out its work through Chan Zuckerberg Biohub, Inc. (a 501(c)(3) medical research organization); Chan Zuckerberg Initiative, LLC (which provides strategic, funding, and operational support); Chan Zuckerberg Initiative Foundation (a 501(c)(3) private foundation); and the Biohub Donor Advised Fund.